Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add filters








Type of study
Year range
1.
Braz. J. Pharm. Sci. (Online) ; 58: e191088, 2022. graf
Article in English | LILACS | ID: biblio-1394055

ABSTRACT

Abstract The objective of this study was to determine the influence of nonionic surfactants on the effectiveness of preservatives used in emulsions containing high surfactant content. Mixtures of different concentrations were prepared between polyethoxylated (40) hydrogenated castor oil (PHCO) and polyoxyethylene sorbitan monooleate (PSO), with methylparaben, phenoxyethanol, methylparaben, ethylparaben, propylparaben, and isobutylparaben (PMEPBI) blend, phenoxyethanol and benzoic acid (BP) blend, and phenoxyethanol and caprylyl glycol (PC) blend. Subsequently, the compatibility of the formulation ingredients and the effectiveness of the preservatives were evaluated by the challenge test. It was found that PHCO and PSO inactivated the antimicrobial action of methylparaben and PMEPBI. Paraben-free preservatives BP and PC had less influence on surfactants than systems containing parabens. When incorporated into microemulsions and nanoemulsions containing 40% and 20% surfactants, methylparaben and BP 0.2% and 0.5% were only effective against Aspergillus niger. The PMEPBI 0.2% was effective as a preservative in nanoemulsified formulations against A. niger, Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. The results demonstrate that the efficacy of the preservative system in formulations containing nonionic surfactant excipients depends on the type of excipient, the components of the formulation, the preservative systems composition, the excipient to preservative ratio, and the availability in the formulation.


Subject(s)
Polysorbates/pharmacology , Surface-Active Agents/pharmacology , Castor Oil/pharmacology , Additives in Cosmetics , Excipients/pharmacology , Effectiveness , Colony Count, Microbial , Microbial Sensitivity Tests , Cosmetic Stability
2.
Braz. J. Pharm. Sci. (Online) ; 58: e18800, 2022. tab, graf, ilus
Article in English | LILACS | ID: biblio-1364431

ABSTRACT

Abstract Efavirenz is one of the most commonly used drugs in HIV therapy. However the low water solubility tends to result in low bioavailability. Drug nanocrystals, should enhance the dissolution and consequently bioavailability. The aim of the present study was to obtain EFV nanocrystals prepared by an antisolvent technique and to further observe possible effect, on the resulting material, due to altering crystallization parameters. A solution containing EFV and a suitable solvent was added to an aqueous solution of particle stabilizers, under high shear agitation. Experimental conditions such as solvent/antisolvent ratio; drug load; solvent supersaturation; change of stabilizer; addition of milling step and solvents of different polarities were evaluated. Suspensions were characterized by particle size and zeta potential. After freeze- dried and the resulting powder was characterized by PXRD, infrared spectroscopy and SEM. Also dissolution profiles were obtained. Many alterations were not effective for enhancing EFV dissolution; some changes did not even produced nanosuspensions while other generated a different solid phase from the polymorph of raw material. Nevertheless reducing EFV load produced enhancement on dissolution profile. The most important modification was adding a milling step after precipitation. The resulting suspension was more uniform and the powder presented grater enhancement of dissolution efficacy.


Subject(s)
Efficacy/classification , HIV/pathogenicity , Crystallization/instrumentation , Dissolution/methods , Particle Size , Solubility , Pharmaceutical Preparations/administration & dosage , Excipients/pharmacology , Dissolution/classification , Nanoparticles/administration & dosage , Methods
3.
Article in English | WPRIM | ID: wpr-223878

ABSTRACT

BACKGROUND: Demineralized bone matrix (DBM) is used for bone healing due to its osteoinductivity, but it requires a carrier for clinical application. Here, we report the effects on the osteoinductivity of DBM by use of a poloxamer 407-based hydrogel as the carrier, compared to sterile water. METHODS: DBM-W and DBM-H represent 27 wt% of DBM with sterile water and DBM with a poloxamer 407-based hydrogel, respectively. Both of the compositions were applied to human mesenchymal stem cell (MSC) cultures, and monitored for alkaline phosphatase (ALP) staining and ALP activity. Six 10-week-old athymic nude rats were used for abdominal muscle grafting with either DBM-W or DBM-H, and were tested by plane radiography, microfocus X-ray computed tomography (CT), and decalcified histology to evaluate ectopic bone formation. RESULTS: The DBM-W group showed stronger ALP staining at 7, 14, and 21 days of treatment, and significantly higher ALP activity at 7 and 14 days of treatment, compared to the DBM-H group. Plane radiography could not confirm the radio-opaque lesions in the rat ectopic bone formulation model. However, ectopic bone formation was observed in both groups by micro-CT. Compared to the DBM-H group, the DBM-W group showed higher bone volume, percent bone volume and trabecular number, and the difference in percent bone volume was statistically significant. Decalcified histology found bony tissue with lamellation in both groups. CONCLUSIONS: Our results suggest that poloxamer 407-based hydrogel has efficacy as a DBM carrier since it shows ectopic bone formation, but its effects on the quality and quantity of osteoblastic differentiation in rat abdominal ectopic bone and MSC are considered negative.


Subject(s)
Animals , Male , Rats , Bone Matrix/physiology , Cell Culture Techniques , Decalcification Technique , Excipients/pharmacology , Hydrogels/pharmacology , Mesenchymal Stem Cells/drug effects , Osteogenesis/drug effects , Poloxamer/pharmacology , Rats, Nude
4.
Arq. bras. cardiol ; 84(3): 251-255, mar. 2005. tab, graf
Article in Portuguese | LILACS | ID: lil-398164

ABSTRACT

OBJETIVO: Avaliar os efeitos vasodilatadores da amiodarona em artérias coronárias caninas empregando soluções de amiodarona dissolvida em polisorbato 80 ou em água. MÉTODOS: Anéis de artéria coronária, com e sem o endotélio íntegro, foram imersos em solução de krebs e conectadas a um transdutor para aferição de força isométrica promovida por contração vascular. As artérias foram expostas a concentrações crescentes de polisorbato 80, amiodarona dissolvida em água, amiodarona dissolvida em polisorbato 80 e uma apresentação comercial da amiodarona (Cordarone®). Os experimentos foram conduzidos na presença e na ausência dos seguintes bloqueadores enzimáticos: apenas indometacina, Nω-nitro-L-arginina associada à indometacina e apenas Nω-nitro-L-arginina. RESULTADOS: O polisorbato 80 causou pequeno relaxamento não dependente do endotélio. O Cordarone®, a amiodarona dissolvida em água e em polisorbato 80 promoveram relaxamento dependente do endotélio, que foi de maior magnitude para a amiodarona dissolvida em polisorbato e para o Cordarone®. Apenas a associação de indometacina com a Nω-nitro-L-arginina foi capaz de abolir o relaxamento dependente do endotélio provocado pela amiodarona dissolvida em polisorbato 80. CONCLUSAO: Os resultados obtidos indicam que a vasodilatação promovida pela amiodarona em artérias coronárias caninas é causada principalmente pela estimulação da liberação de óxido nítrico e fatores endoteliais relaxantes dependentes das ciclo-oxigenases.


Subject(s)
Dogs , Animals , Male , Female , Amiodarone/pharmacology , Coronary Vessels/drug effects , Endothelium, Vascular/drug effects , Endothelium-Dependent Relaxing Factors/pharmacology , Vasodilation/drug effects , Cyclooxygenase Inhibitors/pharmacology , Enzyme Inhibitors/pharmacology , Excipients/pharmacology , Indomethacin/pharmacology , Nitroarginine/pharmacology , Polysorbates/pharmacology
5.
RBM rev. bras. med ; 49(6): 287-8, 291-2, 294, passim, jun. 1992. ilus, tab, graf
Article in Portuguese | LILACS | ID: lil-228153

ABSTRACT

O objetivo desta pesquisa foi quantificar a amplitude de açao, em ratos, de droga antiinflamatória nao esteróide (indometacina), largamente utilizada em cirurgia. Em ensaios clínicos há dificuldade de se quantificar essa açao em termos numéricos, sobre os quais possam ser aplicados testes estatísticos de alto poder de prova. Nesta pesquisa o efeito da indometacina foi quantificado no edema da pata de ratos induzido por carregenia, na pleurisia por carragenina, na inflamaçao crônica por pelotas de algodao implantadas na parede abdominal e no glanuloma de corpo estranho induzido por fio de polipropileno implantado no dorso. Constatou-se que a indometacina reduziu o edema da pata dos ratos tratados para 51 por cento do edema em relaçao ao grupo-controle, o volume do exsudato pleural para 50 por cento, o número de células da pleurisia para 58 por cento e o peso seco do material inflamatório no abdome para 64 por cento. No granuloma induzido no dorso, a indometacina diminuiu o número de neutrófilos para 28 por cento, de macrófagos para 55 por cento, de fibroblastos para 66 por cento e de fibras colágenas para 75 por cento. Concluiu-se que a indometacina reduz siginificativamente a amplitude da inflamaçao aguda e crônica e deve ocupar lugar de destaque no arsenal terapêutico do cirurgiao, atuando na prevençao e no tratamento dos efeitos nicovos da inflamaçao.


Subject(s)
Animals , Male , Rats , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Edema/drug therapy , Indomethacin/therapeutic use , Acute Disease , Carrageenan/pharmacology , Chronic Disease , Edema/chemically induced , Excipients/pharmacology , Foreign Bodies , Hindlimb , Indomethacin/pharmacology , Rats, Inbred Strains
6.
Arq. bras. med ; 66(1): 79-85, jan.-fev. 1992. ilus, tab
Article in Portuguese | LILACS | ID: lil-228172

ABSTRACT

O objetivo desta pesquisa foi investigar a eventual açao antiinflamatória do antibiótico ofloxacina, em ratos. O efeito da ofloxacina foi pesquisado no edema experimental de pata por carragenina e por dextrana, na pleurisia por carragenina, na inflamaçao crônica por pelotas de algodao implantadas na parede abdominal e no granuloma de corpo estranho por fio de polipropileno implantado no dorso. Costatou-se que a ofloxacina nao influenciou a evoluçao da inflamaçao, exceto por inibir (em altas doses) a proliferaçao de células inflamatórias mononucleares do granuloma de corpo estranho formado pela presença de fio de polipropileno. Concluiu-se que a ofloxacina tem açao antiproliferativa sobre células inflamatórias de ratos.


Subject(s)
Animals , Male , Rats , Anti-Infective Agents/pharmacology , Edema , Foreign Bodies , Granuloma , Ofloxacin/pharmacology , Anticoagulants/pharmacology , Carrageenan/pharmacology , Dextrans/pharmacology , Edema/chemically induced , Excipients/pharmacology , Hindlimb , Rats, Wistar
7.
Rev. farm. bioquim ; 11(1/2): 23-31, 1990. tab
Article in Portuguese | LILACS | ID: lil-155918

ABSTRACT

Formulaçöes de comprimidos inertes foram desenvolvidas com a finalidade de se obter formas sólidas para veicular medicamentos homeopáticos. Para tanto, estes devem apresentar comportamento uniforme durante as fases de compressäo e embebiçäo, além de dissolverem-se na boca de forma homogênea e agradável. Foram avaliadas as reologias dos pós e granulados (medidas de ângulo de repouso, densidade aparente e compressibilidade) e as características físicas dos comprimidos (friabilidade, variaçäo de peso médio, dureza e tempo de desintegraçäo). Os comprimidos, de formato lenticular, com 200 mg de peso unitário, foram formulados a partir de lactose (diluente), goma de amido ou xarope simples (aglutinante) e amido em pó (desagregante e lubrificante). Aos granulados foi adicionado estearato de magnésio (lubrificante) e observada a variaçäo de comportamento. A formulaçäo mais adequada continha 90 por cento de lactose, 7,5 por cento de xarope simples, 2,5 por cento de amido em pó e 0,5 por cento de estearato de magnésio.


Subject(s)
Excipients/pharmacology , Homeopathic Vehicles , Rheology , Tablets/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL